A Crossover Safety Study of Ferumoxytol Versus Placebo
Public ClinicalTrials.gov record NCT00255450. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double Blind, Placebo Controlled, Crossover Design, Multicenter Study of Intravenous Ferumoxytol Compared With Placebo
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This crossover safety study will evaluate the safety of a single dose of ferumoxytol compared to placebo in patients with chronic kidney disease.
Study identification
- NCT ID
- NCT00255450
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 750 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2004
- Primary completion
- Not listed
- Completion
- Jul 31, 2006
- Last update posted
- Nov 10, 2008
2005 – 2006
United States locations
- U.S. sites
- 41
- U.S. states
- 26
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mobile | Alabama | 36608 | — |
| Not listed | Phoenix | Arizona | 85012 | — |
| Not listed | Mountain View | California | 94041 | — |
| Not listed | New Haven | Connecticut | 06511 | — |
| Not listed | Washington D.C. | District of Columbia | 20854 | — |
| Not listed | Ocala | Florida | 34471 | — |
| Not listed | Tampa | Florida | 33614 | — |
| Not listed | Atlanta | Georgia | 30308 | — |
| Not listed | Augusta | Georgia | 30901 | — |
| Not listed | Newnan | Georgia | 30265 | — |
| Not listed | Peoria | Illinois | 61603 | — |
| Not listed | Shreveport | Louisiana | 71101 | — |
| Not listed | Shreveport | Louisiana | 71103 | — |
| Not listed | Bethesda | Maryland | 20814 | — |
| Not listed | Boston | Massachusetts | 02135 | — |
| Not listed | Detroit | Michigan | 48236 | — |
| Not listed | St Louis | Missouri | 63136 | — |
| Not listed | Broken Bow | Nebraska | 68822 | — |
| Not listed | Lebanon | New Hampshire | 03756 | — |
| Not listed | Flushing | New York | 11355 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | New York | New York | 10029 | — |
| Not listed | Orchard Park | New York | 14127 | — |
| Not listed | Raleigh | North Carolina | 27609 | — |
| Not listed | Columbus | Ohio | 43210 | — |
| Not listed | Portland | Oregon | 97213 | — |
| Not listed | Erie | Pennsylvania | 16176 | — |
| Not listed | Lancaster | Pennsylvania | 17604 | — |
| Not listed | Greenville | South Carolina | 29605 | — |
| Not listed | Sumter | South Carolina | 29150 | — |
| Not listed | Chattanooga | Tennessee | 37404 | — |
| Not listed | Knoxville | Tennessee | 37923 | — |
| Not listed | Austin | Texas | 78758 | — |
| Not listed | Houston | Texas | 77074 | — |
| Not listed | San Antonio | Texas | 78212 | — |
| Not listed | Alexandria | Virginia | 22304 | — |
| Not listed | Charlottesville | Virginia | 22908 | — |
| Not listed | Chesapeake | Virginia | 23320 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
| Not listed | Bluefield | West Virginia | 24701 | — |
| Not listed | Appleton | Wisconsin | 54911 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00255450, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 10, 2008 · Synced Sep 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00255450 live on ClinicalTrials.gov.